- World Pharma News Home » Corporate » Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
(a free service delivered by FeedBurner)
Pfizer Inc announced today that it has reached agreements in principle to resolve substantially all of the personal injury cases, consumer fraud cases and state attorneys general claims involving its non-steroidal anti-inflammatory (NSAID) pain medication Bextra, which Pfizer voluntarily withdrew from the U.S. market in 2005. Additionally, following key court rulings in favor of Celebrex, claims regarding Celebrex, an effective pain treatment for millions of patients, will also be resolved as part of the settlement.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments